INXN-1001
RTS-M101B'
Phase 1 small_molecule completed
Quick answer
INXN-1001 for Melanoma is a Phase 1 program (small_molecule) at Alaunos Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alaunos Therapeutics
- Indication
- Melanoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed